ChromaDex
Irvine, US
Biotech
Founders & leadership
T1
Tom 10005 Muirlands Blvd., Suite G VarvaroCFO
T1
Troy 10005 Muirlands Blvd., Suite G RhonemusCOO
R1
Reid 10005 Muirlands Blvd., Suite G DabneyDirector
FJ
Frank JakschPresident and CEO
J1
Jeff 10005 Muirlands Blvd., Suite G BaxterDirector
S1
Steven 10005 Muirlands Blvd., Suite G BlockDirector
SA
Steve AllenDirector
R1
Rob 10005 Muirlands Blvd., Suite G FriedDirector
H1
Hugh 10005 Muirlands Blvd., Suite G DunkerleyDirector
Reported raises · per SEC filings
Form D private placements$3.1MraisedOct 2022 · 3 investors · Biotechnology
Rule 506(b)$25MraisedMar 2021 · 1 investors · Biotechnology
Rule 506(b)$5MraisedMay 2020 · 2 investors · Biotechnology
Rule 506(b)$7MraisedAug 2019 · 3 investors · Biotechnology
Rule 506(b)$10MraisedMay 2019 · 2 investors · Biotechnology
Rule 506(b)$23MraisedNov 2017 · 10 investors · Biotechnology
Rule 506(b)$5.1MraisedAug 2017 · 2 investors · Biotechnology
Rule 506(b)$16.4MraisedJun 2017 · 2 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.